Cite
El-Bendary M, Abd-Elsalam S, Elbaz T, et al. Efficacy of combined Sofosbuvir and Daclatasvir in the treatment of COVID-19 patients with pneumonia: a multicenter Egyptian study. Expert Rev Anti Infect Ther. 2021;1-5doi: 10.1080/14787210.2021.1950532.
El-Bendary, M., Abd-Elsalam, S., Elbaz, T., El-Akel, W., Cordie, A., Elhadidy, T., Elalfy, H., Farid, K., Elegezy, M., El-Badrawy, A., Neamatallah, M., Abd Elghafar, M., Salama, M., AbdAllah, M., Essam, M., El-Shazly, M., & Esmat, G. (2021). Efficacy of combined Sofosbuvir and Daclatasvir in the treatment of COVID-19 patients with pneumonia: a multicenter Egyptian study. Expert review of anti-infective therapy, 1-5. https://doi.org/10.1080/14787210.2021.1950532
El-Bendary, Mahmoud, et al. "Efficacy of combined Sofosbuvir and Daclatasvir in the treatment of COVID-19 patients with pneumonia: a multicenter Egyptian study." Expert review of anti-infective therapy vol. (2021): 1-5. doi: https://doi.org/10.1080/14787210.2021.1950532
El-Bendary M, Abd-Elsalam S, Elbaz T, El-Akel W, Cordie A, Elhadidy T, Elalfy H, Farid K, Elegezy M, El-Badrawy A, Neamatallah M, Abd Elghafar M, Salama M, AbdAllah M, Essam M, El-Shazly M, Esmat G. Efficacy of combined Sofosbuvir and Daclatasvir in the treatment of COVID-19 patients with pneumonia: a multicenter Egyptian study. Expert Rev Anti Infect Ther. 2021 Jul 15;1-5. doi: 10.1080/14787210.2021.1950532. Epub 2021 Jul 15. PMID: 34225541.
Copy
Download .nbib